CARDIOVASCULAR INNOVATIONS 2019 JULY 18-20, 2019 Featuring
Complications Pre-Course on July 17HYATT REGENCY DENVER AT COLORADO
CONVENTION CENTER Cardiovascular Innovations 2019 is a world-class
meeting focused on state-of-the-art therapy for peripheral, coronary,
and structural heart disease. The conference features: Highly
interactive expert discussions focused on professional experiences An
emphasis on the latest innovations in interventional cardiovascular
care Live case transmissions by the world's leading operators in the
United States and Europe Satellite symposia and hands-on workshops
TARGET AUDIENCE Cardiovascular Innovations 2019 is designed to meet
the needs of cardiologists, surgeons, internists, trainees,
investigators, nurses, nurse practitioners, physician assistants and
allied health care staff who participate in the care of patients with
coronary, peripheral, and structural cardiovascular diseases. The
focus of the conference is on innovative health care solutions for
these patients. LEARNING OBJECTIVES Establish the diagnosis and select
optimal treatment strategies for patients with both stable and
unstable coronary artery disease. Describe the guideline based
indications and best-practice recommendations for the use of
hemodynamic support devices, intra-vascular imaging techniques, and
physiologic assessment of intravascular hemodynamics, structural heart
devices, antiplatelet, lipid-lowering and antithrombotic drug
interventions. Recognize different manifestations of patient
presentation with carotid disease, acute and chronic DVT, pulmonary
embolism, thoracic and abdominal aortic aneurysms, peripheral artery
disease (PAD) and identify high-risk subsets that would benefit from
revascularization. Outline the risks and benefits of endovascular and
surgical revascularization for patients with CLI. List potential
complications associated with endovascular treatment of carotid
disease, acute and chronic DVT, pulmonary embolism, thoracic and
abdominal aortic aneurysms, and CLI. Define success when treating
complex PAD. Outline the components of a multidisciplinary team for
structural, complex coronary, and CLI. State the goals and identify
the appropriate outcomes when treating end stage PAD and CLI
patients. Identify and treat patients with complex coronary artery,
peripheral vascular, valve, or arrhythmic heart disease. Define
state-of-the-art management pearls to treat patients with
hyperlipidemia, heart failure and structural heart disease. AGENDA
Please check back soon for the 2019 agenda. To join our mailing list
and be notified when the agenda is released, please join our mailing
list here. ACCREDITATION Physicians CMEsolutions has given
preliminary approval for 23 AMA credits. The CMEsolutions is
accredited by the Accreditation Council for Continuing Medical
Education (ACCME) to provide continuing medical education for
physicians. Pharmacists This activity is eligible for ACPE credit;
see final CPE activity announcement for specific details. Nurses This
activity has been submitted to the Continuing Nursing Education
Group, for approval to award nursing contact hours. The Continuing
Nursing Education Group is accredited as an approver of continuing
nursing education by the American Nurses Credentialing Center's
Commission on Accreditation. For more information regarding contact
hours, please call Cardiovascular Innovations Foundation
at 440-821-1026. Radiologic Technologists Category A/A+ CE credit
is pending approval by the ASRT. EXHIBITS & SPONSORSHIP OPPORTUNITIES
Cardiovascular Innovations Foundation is pleased to offer a variety of
sponsorship and exhibit opportunities for CVI2019. Please visit
cvinnovations.org to download the sponsorship opportunitites
prospectus for more information. ABOUT CARDIOVASCULAR INNOVATIONS
FOUNDATION Cardiovascular disease is the number one cause of death
globally, accounting for nearly 17.5 million deaths each year.
Cardiovascular disease may strike those in their prime years and, due
to population aging, also afflict elderly people who are otherwise
living healthy lives. Improvements in cardiovascular therapy have
markedly reduced procedural risk, and thereby enabled the treatment of
a broad range of patients, more than ever before in the history of
medicine. Nonetheless, significant disparities in the delivery of
cardiovascular care continue to exist, leading to large unmet clinical
needs for many patients worldwide. Innovation in the delivery of
cardiovascular care, as well as education of the public at-large, is
essential for optimizing the management of these patients. The
Cardiovascular Innovations Foundation is organized and operated
exclusively for charitable, scientific, and educational purposes
within the meaning of Section 501(c)(3) of the Internal Revenue Code.
The mission of the Foundation is to address unmet needs in
cardiovascular care through the study, design, and development of
innovative health care solutions and education of health care
providers and the larger public. BOARD OF DIRECTORS Subhash Banerjee,
MD, FACC, FSCAIProfessor of MedicineUniversity of Texas Southwestern
Medical CenterChief, Division of CardiologyDirector, Cardiac
Catheterization LaboratoryVA North Texas Health Care SystemEmmanouil
S. Brilakis, MD, PhD, FACC, FAHA, FSCAI, FESCDirector, Center for
Complex Coronary InterventionsMinneapolis Heart Institute at Abbott
Northwestern Hospital Mehdi H. Shishehbor, DO, MPH, PhD, FACC, FAHA,
FSCAIProfessor of Medicine, CWRUCo-Chair, Harrington Heart & Vascular
InstituteDirector, Cardiovascular Interventional CenterCo-Director,
Vascular CenterUniversity Hospitals of ClevelandPaul Sorajja, MD,
FACC, FAHA, FSCAIDirector, Center for Valve and Structural Heart
DiseaseMinneapolis Heart Institute at Abbott Northwestern
HospitalDirector, Valve Science CenterMinneapolis Heart Institute
Foundation
culture
art
business
courses
41
Views
19/07/2019 Last update